Skip to content
healthcare.dev

AMLODIPINE BESYLATE

NDC 51655-044, AMLODIPINE BESYLATE, tablet, from Northwind Health Company, LLC.

Product NDC
51655-044
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077073
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-044 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMLODIPINE BESYLATE5 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]

Package NDCNDC-11Package
51655-044-525165500445230 TABLET in 1 BOTTLE, PLASTIC (51655-044-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0c5784b9-5542-144f-e063-6394a90a7ebc

Use it

Look up 51655-044 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-044 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-044. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.